ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 85 filers reported holding ACCELERON PHARMA INC in Q3 2014. The put-call ratio across all filers is 0.95 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $1,064,000 | -59.8% | 35,000 | -65.0% | 0.18% | -65.0% |
| Q1 2017 | $2,647,000 | +3.7% | 100,000 | 0.0% | 0.52% | -20.0% |
| Q4 2016 | $2,552,000 | -12.8% | 100,000 | +66.7% | 0.65% | +50.9% |
| Q4 2015 | $2,926,000 | +17.5% | 60,000 | -40.0% | 0.43% | +34.6% |
| Q3 2015 | $2,490,000 | -21.3% | 100,000 | 0.0% | 0.32% | +2.6% |
| Q2 2015 | $3,164,000 | +4.6% | 100,000 | 0.0% | 0.31% | -17.1% |
| Q3 2014 | $3,024,000 | +338.3% | 100,000 | +400.0% | 0.37% | +136.7% |
| Q1 2014 | $690,000 | -65.2% | 20,000 | -60.0% | 0.16% | -71.4% |
| Q4 2013 | $1,980,000 | – | 50,000 | – | 0.55% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 2 | $358 | 0.00% |